---

Use of adjuvant intravenous bevacizumab for aggressive recurrent respiratory papillomatosis- A case report

---

Case Report

Author Details : Deepa Shivnani*

Volume : 9, Issue : 3, Year : 2023

Article Page : 96-98

https://doi.org/10.18231/j.ijashnb.2023.019

Suggest article by email

Get Permission

---

Abstract

Recurrent Respiratory Papillomatosis (RRP) is a benign condition which needs frequent surgical interventions for debulking of papillomatosis lesions for securing the airway. There is no definitive treatment for the management of RRP so far. Bevacizumab either intralesional or systemic has emerged as a promising solution for RRP patients undergoing repeated surgeries. We are reporting a case of a 6-year-old child with juvenile onset RRP who was treated by surgical excision of lesion with adjuvant systemic bevacizumab therapy.

Keywords: JORRP, Medical Treatment, Bevacizumab

How to cite : Shivnani D, Use of adjuvant intravenous bevacizumab for aggressive recurrent respiratory papillomatosis- A case report. IP Indian J Anat Surg Head Neck Brain 2023;9(3):96-98

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.